These data suggest that early postnatal administration of AAV-PKP2 prevents the electrical deficits, including ventricular depolarization delay and cardiac arrhythmias, in PKP2 Hom mice in the long term (6 months). Here, PKP2 is linked to cardiac rhythm disease.